v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
Total
Additional paid-in capital
Common stock held in treasury
Accumulated other comprehensive income (loss)
Retained earnings (loss)
Non-controlling interest
Class A common stock
Class A common stock
Common Stock
Class B common stock
Class B common stock
Common Stock
HMH Holding BV And Subsidiaries [Member]
HMH Holding BV And Subsidiaries [Member]
Common Stock
HMH Holding BV And Subsidiaries [Member]
Additional paid-in capital
HMH Holding BV And Subsidiaries [Member]
Hedging Reserve [Member]
HMH Holding BV And Subsidiaries [Member]
Pension Remeasurement Reserve [Member]
HMH Holding BV And Subsidiaries [Member]
Currency Translation Reserve [Member]
HMH Holding BV And Subsidiaries [Member]
Accumulated other comprehensive income (loss)
HMH Holding BV And Subsidiaries [Member]
Retained earnings (loss)
HMH Holding BV And Subsidiaries [Member]
Non-controlling interest
HMH Holding BV And Subsidiaries [Member]
Class A common stock
HMH Holding BV And Subsidiaries [Member]
Class B common stock
Beginning balance, shares outstanding (in shares) at Dec. 31, 2023                       200,000                  
Beginning balance at Dec. 31, 2023                     $ 593,131,000 $ 0 $ 601,539,000 $ 1,098,000 $ 1,220,000 $ 2,003,000 $ 4,321,000 $ (12,729,000) $ 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Other comprehensive income (loss)                     (23,074,000)     (3,348,000) 842,000 (20,568,000) (23,074,000)        
Sale ownership interest in Hydril Arabia                     9,324,000   8,892,000           432,000    
Net income (loss)                     $ 51,956,000             51,218,000 738,000    
Ending balance, shares outstanding (in shares) at Dec. 31, 2024               0   0 200 200,000                 100
Ending balance at Dec. 31, 2024 $ 631,337,000 $ 610,431,000 $ 0 $ (18,753,000) $ 38,489,000 $ 1,170,000   $ 0   $ 0 $ 631,337,000 $ 0 610,431,000 (2,250,000) 2,062,000 (18,565,000) (18,753,000) 38,489,000 1,170,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Other comprehensive income (loss) 22,364,000     22,364,000                                  
Net income (loss) 15,646,000       15,061,000 585,000         $ 15,646,000                    
Ending balance, shares outstanding (in shares) at Jun. 30, 2025               0   0                      
Ending balance at Jun. 30, 2025 669,347,000 610,431,000 0 3,611,000 53,550,000 1,755,000   $ 0   $ 0                      
Beginning balance, shares outstanding (in shares) at Dec. 31, 2024               0   0 200 200,000                 100
Beginning balance at Dec. 31, 2024 631,337,000 610,431,000 0 (18,753,000) 38,489,000 1,170,000   $ 0   $ 0 $ 631,337,000 $ 0 610,431,000 (2,250,000) 2,062,000 (18,565,000) (18,753,000) 38,489,000 1,170,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Other comprehensive income (loss)                     22,992,000     2,715,000 629,000 19,648,000 22,992,000        
Net income (loss)                     $ 46,123,000             45,454,000 669,000    
Ending balance, shares outstanding (in shares) at Dec. 31, 2025               0   0 200 200,000               100  
Ending balance at Dec. 31, 2025 700,452,000 610,431,000   4,239,000 83,943,000 1,839,000   $ 0   $ 0 $ 700,452,000 $ 0 610,431,000 465,000 2,691,000 1,083,000 4,239,000 83,943,000 1,839,000    
Beginning balance, shares outstanding (in shares) at Mar. 31, 2025               0   0                      
Beginning balance at Mar. 31, 2025 650,794,000 610,431,000 0 (5,174,000) 44,601,000 936,000   $ 0   $ 0                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Other comprehensive income (loss) 8,785,000     8,785,000                                  
Net income (loss) 9,768,000       8,949,000 819,000                              
Ending balance, shares outstanding (in shares) at Jun. 30, 2025               0   0                      
Ending balance at Jun. 30, 2025 669,347,000 610,431,000 0 3,611,000 53,550,000 1,755,000   $ 0   $ 0                      
Beginning balance, shares outstanding (in shares) at Dec. 31, 2025               0   0 200 200,000               100  
Beginning balance at Dec. 31, 2025 700,452,000 610,431,000   4,239,000 83,943,000 1,839,000   $ 0   $ 0 $ 700,452,000 $ 0 $ 610,431,000 $ 465,000 $ 2,691,000 $ 1,083,000 $ 4,239,000 $ 83,943,000 $ 1,839,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net income Prior To The Corporate Reorganization Transactions 3,875,000       3,448,000 427,000                              
Other comprehensive income (loss) 3,619,000                                        
Other comprehensive income prior to the Corporate Reorganization Transactions 5,600,000     5,600,000                                  
Issuance of common stock in initial public offering, net of offering costs (in shares)               11,206   32,578                      
Issuance of common stock in initial public offering, net of offering costs 210,670,000 210,232,000           $ 112,000   $ 326,000                      
Redemption under exchange agreement with Principal Stockholders (in shares)                   (686)                      
Redemption under exchange agreement with Principal Stockholders (12,894,000) 631,000       (13,518,000)       $ (7,000)                      
Purchase of HMH B.V. voting shares from Principal Stockholders (39,480,000) (39,480,000)                                      
Effect of the Corporate Reorganization Transactions 0 (570,015,000)   (7,296,000) (64,801,000) 642,112,000                              
IPO related costs (26,189,000) (26,189,000)                                      
TRA liability and related deferred tax impact from the Corporate Reorganization Transactions (6,522,000) (6,522,000)                                      
Net income (loss) subsequent to the Corporate Reorganization Transactions (5,019,000)       4,976,000 (9,995,000)                              
Net income (loss) (1,144,000)                   $ (1,144,000)                    
Share-based compensation (in shares)               837                          
Share-based compensation 22,775,000 6,045,000       16,722,000   $ 8,000                          
Purchase of treasury stock (4,888,000)   (4,888,000)                                    
Other Comprehensive Income Subsequent To The Corporate Reorganization Transactions (1,981)     (532)   (1,449)                              
Ending balance, shares outstanding (in shares) at Jun. 30, 2026               12,043 31,891,652 31,892 63,783,304                 12,042,625 31,891,652
Ending balance at Jun. 30, 2026 846,399,000 185,133,000 (4,888,000) 2,011,000 27,566,000 636,138,000   $ 120,000   $ 319,000                      
Beginning balance, shares outstanding (in shares) at Mar. 31, 2026               0   0                      
Beginning balance at Mar. 31, 2026 709,927,000 610,431,000 0 9,839,000 87,391,000 2,266,000   $ 0   $ 0                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Other comprehensive income (loss) (1,981,000)     (532,000)   (1,449,000)                              
Issuance of common stock in initial public offering, net of offering costs (in shares)               11,206   32,578                      
Issuance of common stock in initial public offering, net of offering costs 210,670,000 210,232,000           $ 112,000   $ 326,000                      
Redemption under exchange agreement with Principal Stockholders (in shares)                   (686)                      
Redemption under exchange agreement with Principal Stockholders (12,894,000) 631,000       (13,518,000)       $ (7,000)                      
Purchase of HMH B.V. voting shares from Principal Stockholders (39,480,000) (39,480,000)                                      
Effect of the Corporate Reorganization Transactions 0 (570,015,000)   (7,296,000) (64,801,000) 642,112,000                              
IPO related costs (26,189,000) (26,189,000)                                      
TRA liability and related deferred tax impact from the Corporate Reorganization Transactions (6,522,000) (6,522,000)                                      
Net income (loss) (5,019,000)       4,976,000 (9,995,000)                              
Share-based compensation (in shares)               837                          
Share-based compensation 22,775,000 6,045,000       16,722,000   $ 8,000                          
Purchase of treasury stock (4,888,000)   (4,888,000)                                    
Ending balance, shares outstanding (in shares) at Jun. 30, 2026               12,043 31,891,652 31,892 63,783,304                 12,042,625 31,891,652
Ending balance at Jun. 30, 2026 846,399,000 $ 185,133,000 $ (4,888,000) $ 2,011,000 $ 27,566,000 $ 636,138,000   $ 120,000   $ 319,000                      
Beginning balance, shares outstanding (in shares) at Apr. 01, 2026                                       100 100
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Redemption under exchange agreement with Principal Stockholders (in shares)             (2,100,000)   (2,100,000)                        
Purchase of HMH B.V. voting shares from Principal Stockholders $ (39,500,000)                                        
Share-based compensation (in shares)             836,781